Tag: tech
CynLr and IISc partner to decode biological vision for real-world robotics
Through joint research, the partnership will convert neural insights into robotic perception systems, laying foundations for generalized manipulation and Universal Factories
Reveal HealthTech raises $7.2M Series A led by Leo Capital to...
Reveal helps healthcare organizations identify their most valuable problems and build safe, clinically relevant systems to solve them
India’s medical devices now meet 30% of domestic needs, with exports...
‘India MedTech Expo 2025’ concludes with Department of Pharmaceuticals reiterating commitment to make India ‘Atmanirbhar’ in MedTech sector
AliveCor launches groundbreaking AI-powered Kardia 12L ECG System in India
Kardia 12L, which has received Central Drugs Standard Control Organisation (CDSCO) approval for use in India, detects 35 cardiac determinations
IHH Healthcare debuts bold new identity & FutureHealth.Now leadership conference
Poised to catalyse next-level care through meaningful innovation, powerful synergies and strategic partnerships
GST rejig may impact competitiveness of medical devices; AiMeD urges balanced...
AiMeD noted that proposed GST changes—to either 5% or 18%—both present significant risks requiring carefully nuanced consideration
In a first, Terumo launches ‘Terufusion’ advanced infusion systems in India
Terufusion™ Advanced Infusion Systems combine a Smart Syringe Pump, Smart Infusion Pump (volumetric), and Pump Monitoring System (PMS) software for precise and efficient drug administration
IIT Guwahati develops deep learning-based sensor for people with voice disabilities
On a lab-scale, the working prototype has been developed for Rs. 3000
Marengo Asia Hospitals enters into a strategic clinical partnership with Metis...
This collaboration brings together the strengths of and Marengo Asia Hospitals and Metis to build future-ready centers of excellence in a region witnessing significant growth in demand for advanced and quality healthcare
India’s pharma exports surpass USD 30 Billion in FY2025 and aim...
The Rubix report further points to a clear shift in strategic priorities among Indian pharma firms, particularly as global risks mount






























































